Selective sPlenic flExure Mobilization for Low ColorEctal Anastomosis After D3 lYmph Node Dissection (SPEEDY) Trial: A Study Protocol
Colorectal cancer (CRC) persists as a leading cause of cancer mortality globally, necessitating continuous refinement of surgical strategies to optimize outcomes. Total mesorectal excision (TME), introduced by Heald et al., remains the gold standard for rectal cancer resection, significantly improving oncological results. However, challenges persist in determining the optimal approach for restoring bowel continuity after low anterior resection (LAR), particularly regarding anastomotic techniques and vascular ligation strategies. The SPEEDY trial addresses these issues by comparing two surgical approaches: high-tie inferior mesenteric artery (IMA) ligation with routine splenic flexure mobilization (SFM) versus low-tie IMA ligation with selective SFM.
Surgical Context and Rationale
Following TME, surgeons face critical decisions during LAR, including whether to ligate the IMA proximally (high-tie) or distally (low-tie) and whether to routinely mobilize the splenic flexure. High-tie ligation, which involves dividing the IMA at its origin, facilitates extensive lymphadenectomy and may improve survival but risks impaired blood flow to the anastomosis. To compensate for reduced vascular supply, routine SFM is often performed to ensure tension-free anastomosis. However, SFM introduces technical complexity, prolongs operative time, and carries a 2.5% risk of splenic injury. Conversely, low-tie ligation preserves the left colic artery (LCA), potentially maintaining adequate perfusion to the descending colon without mandatory SFM. A critical anatomical consideration is the arcade of Riolan, an inconstant vascular network that may compensate for reduced perfusion; its absence or variability underscores the need for individualized approaches.
Retrospective studies report conflicting outcomes. While some suggest high-tie ligation offers stage-specific survival benefits, others demonstrate that low-tie ligation without SFM reduces operative complexity and time without compromising outcomes. Approximately 26% of patients require SFM to achieve sufficient colon length for tension-free anastomosis, highlighting the need for selective rather than routine mobilization.
Trial Design and Objectives
The SPEEDY trial is a prospective, randomized study enrolling patients with histologically confirmed rectal adenocarcinoma (Stage I–III), located within 15 cm of the anal verge, and without sphincter involvement. Exclusion criteria include metastatic disease, urgent surgery, and sphincter-invasive tumors. Participants are randomized into two arms:
- High-tie group: IMA ligated at its origin with routine SFM.
- Low-tie group: IMA ligated distal to the LCA with SFM performed only if intraoperative assessment indicates insufficient colon length.
Both groups undergo TME with D3 lymph node dissection (en bloc removal of lymph nodes along the IMA and its primary branches) and stapled side-to-end colorectal anastomosis. Hydropneumatic leak testing is standard, and all patients receive a diverting loop ileostomy or transverse colostomy. Postoperative follow-up includes clinical evaluation and proctography at 4–6 weeks to assess anastomotic integrity.
Primary and Secondary Outcomes
The primary endpoint is the rate of anastomotic leak (AL), defined as clinical or radiological evidence of leakage within 6 weeks postoperatively. AL is a devastating complication associated with prolonged hospitalization, increased mortality, and long-term functional impairment.
Secondary endpoints include:
- Operative metrics: SFM rate in the low-tie group, operative time, conversion rates (for laparoscopic cases), and splenic injury incidence.
- Oncological outcomes: Number of harvested lymph nodes, pathological staging accuracy, and resection margin status.
- Morphometric data: Colon length before and after SFM, vascular branching patterns, and IMA architecture.
- Postoperative outcomes: Complication rates (surgical site infections, stoma-related issues), hospital stay duration, and short-term functional results.
- Long-term follow-up: Disease-free and overall survival, though these require extended follow-up beyond the trial’s initial scope.
Surgical Technique and Innovations
The trial emphasizes standardization across both arms. Laparoscopic or open approaches are permitted, reflecting real-world surgical practice. Key technical details include:
- D3 lymphadenectomy: Complete dissection of lymph nodes along the IMA, aorta, and iliac vessels.
- SFM criteria in the low-tie group: SFM is performed only if intraoperative measurement confirms insufficient colon length after low-tie ligation. This selective approach aims to minimize unnecessary dissection.
- Anastomotic integrity: Hydropneumatic testing involves insufflating air under saline to detect leaks, followed by reinforced suturing if required.
Statistical Considerations
A sample size of 76 patients per arm was calculated to detect a 15% difference in AL rates with 80% power. Intention-to-treat analysis will be applied. Continuous variables (operative time, lymph node count) will be analyzed using Student’s t-test or Mann-Whitney U-test, while categorical variables (AL rates, complications) will use Pearson’s χ² or Fisher’s exact test. Baseline characteristics (age, tumor stage) will be compared to confirm randomization efficacy.
Anticipated Challenges and Innovations
The trial’s design addresses several limitations of prior studies. Retrospective analyses, such as Mouw et al.’s work, suggested SFM improves nodal staging but lacked standardized protocols. Conversely, a meta-analysis by Gachabayov et al. highlighted increased operative time and infection risks with SFM but acknowledged selection bias. SPEEDY mitigates these issues through rigorous randomization and explicit SFM criteria.
A key innovation is the integration of selective SFM with low-tie ligation. By preserving the LCA and avoiding routine SFM, the trial may demonstrate equivalent AL rates with reduced operative morbidity. Additionally, detailed vascular mapping (e.g., prevalence of Riolan’s arcade) may inform future surgical planning.
Clinical Implications
If the low-tie approach demonstrates non-inferiority in AL rates, it could redefine standards for rectal cancer surgery. Benefits may include:
- Reduced operative time: Omitting routine SFM may shorten procedures, particularly in laparoscopic cases.
- Lower complication rates: Minimizing SFM could decrease splenic injury and infection risks.
- Enhanced laparoscopic feasibility: Low-tie ligation simplifies vascular dissection, potentially increasing minimally invasive surgery adoption.
Limitations
The trial’s focus on surgical and short-term outcomes necessitates follow-up studies to evaluate long-term survival and recurrence. Additionally, surgeon expertise and heterogeneity in neoadjuvant therapy regimens may introduce variability, though randomization aims to balance these factors.
Conclusion
The SPEEDY trial represents a pivotal effort to optimize rectal cancer surgery by challenging the dogma of routine SFM and high-tie ligation. Through meticulous comparison of two standardized approaches, the study aims to provide evidence-based guidelines for balancing oncological efficacy with surgical safety. Results may establish selective SFM as a viable strategy, reducing morbidity while maintaining the principles of radical cancer surgery.
DOI: 10.1097/CM9.0000000000000914
Was this helpful?
0 / 0